Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 322

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 322
---
 order to have committed a violation;                                                |

| • |     | Federal criminal laws that prohibit executing a scheme to defraud any healthcare benefit program or making, or 
 causing to be made, false statements relating to healthcare matters;                                           |

| • |     | the federal Civil Monetary Penalties Law, which prohibits, among other things, offering or transferring                                                                                                                                            
 remuneration to a federal healthcare beneficiary that a person knows or should know is likely to influence the beneficiary’s decision to order or receive items or services reimbursable by the government from a particular provider or supplier; |

| • |     | the Foreign Corrupt Practices Act, the U.K. Bribery Act of 2010, and other local anti-corruption laws that apply 
 to our international activities;                                                                                 |

| • |     | the federal Physician Payment Sunshine Act (“Open Payments”), and implementing regulations, which                                                                                                   
 require applicable group purchasing organizations and manufacturers of covered drugs, medical devices, biologicals and medical supplies for which payment is available under Medicare, Medicaid, or |

- 225 -

| the Children’s Health Insurance Program to report annually to the CMS information related to certain payments and other transfers of value made to covered recipients, including licensed                   
 physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain non-physician healthcare professionals (such as physician assistants and nurse practitioners, among 
 others), and teaching hospitals, and information regarding ownership and investment interests held by physicians and their immediate family members;                                                        |

| • |     | analogous state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false                                                                                                                                          
 claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers or patients; state laws that require pharmaceutical manufacturers to comply with the industry’s voluntary compliance guidelines     
 and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require manufacturers to report information  
 related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially 
 harm customers; foreign and state laws, including the EU General Data Protection Regulation (“GDPR”) and a version of the GDPR adopted in the United Kingdom (“UK GDPR”), and state laws and regulations, including general                             
 legislation such as the California Consumer Protection Act (“CCPA”), and sector- or subject